Neonatally streptozotocin-induced (n-STZ) diabetic rats: A family of type 2 diabetes models

Animal Models of Diabetes, Second Edition: Frontiers in Research

Volumn , Issue , 2007, Pages 223-250

  Portha, B ^a   Movassat, J ^a   Cuzin Tourrel, C ^a   Bailbe, D ^a   Giroix, M H ^a   Serradas, P ^a   Dolz, M ^a   Kergoat, M ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre de Recherches   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014464007     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (125)

1. Ahren B, Skoglund G. (1989) Insulin secretion in neonatally streptozotocin-injected mice. Diabetes Res 11:185-190.
2. Alper G, Olukman M, Irer S, et al. (2005) Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat. Diabetes Metab Res Rev 22:190-197.
3. Angel I, Burcelin R, Prouteau M, et al. (1996) Normalization of insulin secretion by a selective alpha2-adrenoceptor antagonist restores Glut-4 glucose transporter in adipose tissues of type II diabetic rats. Endocrinology 137:2022-2027.
4. Ashokkumar N, Pari L. (2005) Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 351:105-113.
5. Barbera A, Fernandez-Alvarez J, Truc A, et al. (1997) Effects of tungstate in neonatally streptozotocin-induced diabetic rats: Mechanism leading to normalization of glycemia. Diabetologia 40:143-149.
6. Bevilacqua S, Barett EJ, Smith D, et al. (1985) Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. Metabolism 34:817-825.
7. Blondel O, Bailbe D, Portha B. (1989) Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozotocin as neonates. Diabetes 36:610-617.
8. Blondel O, Bailbe D, Portha B. (1990) Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: Evidence for reversal following phlorizin treatment. Metabolism 39:787-793.
9. Blondel O, Simon J, Chevalier B, Portha B. (1990) Impaired insulin action but normal insulin receptor activity in the liver of diabetic rats. Effect of vanadate treatment. Am J Physiol 258:E459-E467.
10. Bonner-Weir S, Orci L. (1982) New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-889.
11. Bonner-Weir S, Trent DF, Honey RN, Weir GC. (1981) Responses of neonatal islets to streptozotocin: Limited B-cell regeneration and hyperglycemia. Diabetes 30:64-69.
12. Cantenys D, Portha B, Dutrillaux MC, et al. (1981) Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin. An immunocytochemical study. Virchows Arch Cell Pathol 35:109-122.
13. Dachicourt N, Serradas P, Bailb D, et al. (1997) GLP-1(7-36) amide confers glucose sensitivity to previously glucose-incompetent B-cells in diabetic rats. In vivo and in vitro studies. J Endocrinol 155:369-376.
14. DeFronzo RA, Hendler R, Simonson D. (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31:795-801.
15. Dutrillaux MC, Portha B, Roze C, Hollande E. (1982) Ultrastructural study of pancreatic Bcell regeneration in newborn rats after destruction by streptozotocin. Virchows Arch Cell Pathol 39:173-185.
16. Eizirik D, Sandler S, Welsh N, Hellerstrom C. (1988) Preferential reduction of insulin production in mouse pancreatic islet maintained in culture after streptozotocin exposure. Endocrinology 122:1242-1249.
17. Elian N, Bensimon C, Chapa O, et al. (1996) Pancreatic transplantation in experimental noninsulin dependent diabetic rats. Transplantation 61:696-700.
18. Fantus IG, Chayoth R, O’Dea L, et al. (1987) Insulin binding and glucose transport in adipocytes in neonatal streptozotocin-injected rat model of diabetes mellitus. Diabetes 36:654-660.
19. Fernandez-Alvarez J, Barbera A, Nadal B, et al. (2004) Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia 47:470-477.
20. Ferrand N, Astesano A, Phan HH, et al. (1995) Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats. Am J Physiol 269:C1250-1264.
21. Frayon S, Pessah M, Giroix MH, et al. (1999) Golf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin dependent diabetes. Biochem Biophys Res Commun 254:269-272.
22. Friedman MI. (1972) Effects of alloxan diabetes on hypothalamic hyperphagia and obesity. Am J Physiol 222:174-178.
23. Garofano A, Czernichow P, Breant B. (2000) Impaired beta-cell regeneration in perinatally malnourished rats: A study with STZ. FASEB J 14:2611-2617.
24. Giroix M-H, Baetens D, Rasschaert J, et al. (1992) Enzymic and metabolic anomalies in islets of diabetic rats: Relationship to B-cells mass. Endocrinology 130:2634-2640.
25. Giroix MH, Portha B, Kergoat M, et al. (1983) Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes: A study with the perfused pancreas. Diabetes 32:445-451.
26. Giroix M-H, Portha B, Kergoat M, Picon L. (1984) Glucagon secretion in rats with noninsulin- dependent diabetes: an in vivo and in vitro study. Diabètes Metabol 10:12-17.
27. Giroix MH, Rasschaert J, Bailbe D, et al. (1991) Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozotocin. Diabetes 40:227-232.
28. Giroix MH, Rasschaert J, Sener A, et al. (1992) Study of hexose transport, glycerol phosphate shuttle and Krebs cycle in islets of adult rats injected with streptozotocin during the neonatal period. Mol Cell Endocrinol 83:95-104.
29. Giroix MH, Sener A, Bailbe D, et al. (1990) Impairment of the mitochondrial oxidative response to D-glucose in pancreatic islets from adult rats injected with streptozotocin during the neonatal period. Diabetologia 33:654-660.
30. Giroix MH, Sener A, Portha B, Malaisse WJ. (1993) Preferential alteration of oxidative relative to total glycolysis in pancreatic islets of two rat models of inherited or acquired type (non-insulin-dependent) diabetes mellitus. Diabetologia 36:305-309.
31. Grill V, Ostenson CG. (1988) The influence of a diabetic state on insulin secretion: Studies in animal models of non-insulin dependent diabetes. In Pathogenesis of Non- Insulin-Dependent Diabetes Mellitus, ed. Grill V, Efendic S. Raven Press, New York, 93-106.
32. Grill V, Rundfeldt M. (1986) Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozotocin-diabetic and dexamethasone-treated rats: Role of hyperglycemia and increased B-cell demands. Diabetes 35:44-51.
33. Grill V, Welsberg C, Ostenson CG. (1987) b-Cell sensitivity in a rat model of non-insulindependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. J Clin Invest 80:664-669.
34. Gutzeit A, Renold AE, Cerasi E, Shafrir E. (1979) Effect of diet-induced obesity on glucose and insulin tolerance of a rodent with a low insulin response (Acomys cahirinus). Diabetes 28:777-784.
35. Halban PA, Bonner-Weir S, Weir GC. (1983) Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus. Diabetes 32:277-283.
36. Hasegawa G, Mori H, Sawada M, et al. (1989) Overt diabetes induced by overeating in neonatally STZ-treated impaired glucose tolerant mice: Long-term follow-up study. Endocrinol Jpn 36:471-479.
37. Inoue K, Cetkovic-Cvrlje M, Eizirik D, Grill V. (1994) Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats. Diabetologia 37:351-357.
38. Inoue K, Hisatomi A, Umeda F, Nawata H. (1992) Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment. Diabetes 41:723-727.
39. Irako T, Akamizu T, Hosoda H, et al. (2006) Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats Diabetologia. In press [Epub ahead of print].
40. Iwase M, Kikuchi M, Nunoi K, et al. (1987) Diabetes induced by neonatal streptozotocin treatment in spontaneously hypertensive rats. Metabolism 36:654-657.
41. Iwase M, Nunoi K, Himeno H, et al. (1994) Susceptibility to neonatal streptozotocin-induced diabetes in spontaneously hypertensive rats. Pancreas 9:344-348.
42. Iwase M, Wakisaka M, Yoshinari M, et al. (1996) Effect of gonadectomy on the development of diabetes mellitus, hypertension, and albuminuria in the rat model. Metabolism 45:155-161.
43. Junod A, Lambert A, Stauffacher W, Renold AE. (1969) Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest 48:2129-2139.
44. Kahn A, Chandramouli V, Ostenson CG, et al. (1990) Glucose cycling in islets from normal and diabetic rats. Diabetes 39:456-459.
45. Kasono K, Yasu T, Kakehashi A, et al. (2004) Nicorandil improves diabetes and rat islet betacell damage induced by streptozotocin in vivo and in vitro. Eur J Endocrinol 151:277-285.
46. Kawai K, Suzuki S, Murayama Y, et al. (1991) Comparison of beta-cell function after longterm treatment with insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin- induced non-insulin-dependent diabetic rats. Diabetes Res Clin Pract 12:163-172.
47. Kawai K, Suzuki S, Watanabe Y, et al. (1991) Neonatal streptozotocin monosodium-glutamate injection in rats: A model of obese NIDDM. In Lessons from Animal Diabetes. The Tokyo Workshop, ed. Goto Y, Kanazawa Y. Smith-Gordon, London, 45-49.
48. Kergoat M, Bailbe D, Portha B. (1987a) Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozotocin. Diabetes 36:971-977.
49. Kergoat M, Bailbe D, Portha B. (1987b) Effect of high-sucrose diet on the insulin secretion and insulin action. A study in the normal rat. Diabetologia 30:252-258.
50. Kergoat M, Bailbe D, Portha B. (1987c) Effect of high sucrose diet on insulin secretion and insulin action. A study in rats with non-insulin dependent diabetes induced by streptozotocin. Diabetologia 30:666-673.
51. Kergoat M, Guerre-Millo M, Lavau M, Portha B. (1991) Increased insulin action in rats with mild insulin deficiency induced by neonatal streptozotocin. Am J Physiol 260:E561-567.
52. Kergoat M, Portha B. (1985) In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozotocin. Diabetes 34:574-579.
53. Kergoat M, Simon J, Portha B. (1988) Insulin receptor binding and tyrosine kinase activity in the liver of rats with non-insulin-dependent diabetes. Biochem Biophys Res Commun 152:1015-1022.
54. Kim BM, Ha YM, Shin YJ, et al. (2001) Clusterin expression during regeneration of pancreatic islets cells in streptozotocin-induced diabetic rats. Diabetologia 44:2192-2202.
55. Kurose T, Tsuda K, Ishida H, et al. (1992) Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro. Diabetologia 35:1035-1041.
56. Leahy JL, Bonner-Weir S, Weir GC. (1984) Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33:667-673.
57. Leahy JL, Bonner-Weir S, Weir GC. (1985) Abnormal insulin secretion in a streptozotocin model of diabetes. Effects of insulin treatment. Diabetes 34:660-666.
58. Leahy JL, Weir GC. (1985) Unresponsiveness to glucose in a streptozotocin model of diabetes; inappropriate insulin and glucagon responses to a reduction of glucose concentration. Diabetes 34:653-659.
59. LeDoux SP, Woodley SE, Patton NJ, Wilson GL. (1986) Mechanisms of nitrosourea-induced b-cell damage. Alterations in DNA. Diabetes 35:866-872.
60. Leiter EH, Coleman DL, Eisenstein AB, Strack I. (1981) Dietary control of pathogenesis in C57 BL/KsJ db/db diabetic mice. Metabolism 30:554-562.
61. Levy J, Gavin JR, Fausto A, et al. (1984) Impaired insulin action in rats with non-insulindependent diabetes. Diabetes 33:901-906.
62. Levy J, Suzuki Y, Avioli L, et al. (1988) Plasma membrane phospholipid content in noninsulin- dependent streptozotocin-diabetic rats-Effect of insulin. Diabetologia 31:315-321.
63. Li L, Yi Z, Seno M, Kojima I. (2004) Activin A and betacellulin: Effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 53:608-615.
64. Malaisse WJ. (1991) Regulation of insulin secretion by nutrients. In Nutrient Regulation of Insulin Secretion, ed. Flatt PR. Portland Press, London, 83-100.
65. Mann JI. (1980) Diet and diabetes. Diabetologia 18:89-95.
66. McEvoy R, Madson KL. (1980) Pancreatic insulin, glucagon and somatostatin positive islet cell populations during perinatal development of the rat. Morphometric quantitation. Biol Neonate 37:248-254.
67. Melin B, Caron M, Cherqui G, et al. (1991) Increased insulin action in cultured hepatocytes from rats with diabetes induced by neonatal streptozotocin. Endocrinology 182: 1693-1701.
68. Mende S, Mühle W, Peters W. (1996) Influence of postnatal overnutrition and pregnancy on non-insulin dependent diabetes induced in Wistar rats by neonatal streptozotocin. Horm Metab Res 28:81-85.
69. Morin L, Giroix M-H, Gangnerau M-N, et al. (1997) Impaired phosphoinositide metabolism in glucose-incompetent islets of neonatally streptozotocin-diabetic rats. Am J Physiol 272:E737-E745.
70. Movassat J, Portha B. (1999) Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth. Diabetologia 42:1098-1100.
71. Movassat J, Saulnier C, Portha B. (1997) Insulin administration enhances growth of the betacell mass in streptozotocin-treated newborn rat. Diabetes 46:1445-1452.
72. Nakayama K, Murakami N, Ohta M, et al. (1995) Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats. Eur J Pharmacol 276:85-91.
73. Ogata T, Dunbar AJ, Yamamoto Y, et al. (2005) Betacellulin-delta4, a novel differentiation factor for pancreatic beta-cells, ameliorates glucose intolerance in streptozotocintreated rats. Endocrinology 146:4673-4681.
74. Ogata T, Li L, Yamada S, Yamamoto Y, Tanaka Y, Takei I, Umezawa K, Kojima I. (2004) Promotion of beta-cell differentiation by conophylline in fetal and neonatal rat pancreas. Diabetes 53:2596-2602.
75. Ohnota H, Kitamura T, Kinikawa M, et al. (1996) A rapid and short-acting hypoglycemic agent KAD-1229 improves postprandial hyperglycemia and diabetic complications in streptozotocin-induced non-insulin-dependent diabetes mellitus rats. Jpn J Pharmacol 71:315-323.
76. Ohnota H, Koizumi M, Momose Y, Sato F. (1994) Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium(2S)-2-benzyl-3-(cis-hexahydro-2- isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus rats. Can J Pharmacol 73:1-6.
77. Ohta T, Furukawa N, Yonemori F, Wakitani K. (1999) JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetic mellitus rats. Eur J Pharmacol 367:91-99.
78. Okabayashi Y, Otsuki M, Ohki A, et al. (1989) Increased B-cell secretory responsiveness to ceruletide and TPA in streptozotocin-induced mildly diabetic rats. Diabetes 38:1042-1047.
79. Okamoto H. (1981) Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37:43-61.
80. Östenson CG, Cattaneo AG, Doxey JC, Efendic S. (1989) a-Adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am J Physiol 257:E439-E443.
81. Östenson CG, Efendic S, Grill V. (1990) Abnormal regulation by glucose and somatostatin secretion in the perfused pancreas of NIDDM rats. Pancreas 5:347-353.
82. Östenson CG, Grill V. (1985) Glucose exerts opposite effects on muscarinic receptor binding to A and B cells of the endocrine pancreas. Endocrinology 116:1741-1745.
83. Östenson CG, Grill V. (1987) Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology 121:1705-1710.
84. Östenson C, Grill V, Roos M. (1989) Studies on sex dependency of b-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus. Exp Clin Endocrinol 93:241-247.
85. Pari L, Ashokkumar N. (2005) Effect of N-benzoyl-D-phenylalanine, a new potential oral antidiabetic agent, in neonatal streptozotocin-induced diabetes in rats. Pharmacol Rep 57:498-503.
86. Portha B. (1985) Decreased glucose-induced insulin release and biosynthesis by islets of rats with non-insulin-dependent diabetes: Effects of tissue culture. Endocrinology 117:1735-1741.
87. Portha B, Blondel O, Serradas P, et al. (1989) The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab 15:61-75.
88. Portha B, Chamras H, Broer Y, et al. (1983) Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type II diabetes. Mol Cell Endocrinol 32:13-26.
89. Portha B, Giroix MH, Picon L. (1982) Effect of diet on glucose tolerance and insulin response in chemically diabetic rats. Metabolism 21:1194-1199.
90. Portha B, Giroix MH, Serradas P, Malaisse WJ, et al. (1988) Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes 37:226-233.
91. Portha B, Goursot R, Giroix MH, et al. (1983) Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat. Diabetologia 25:51-55.
92. Portha B, Kergoat M. (1985) Dynamics of glucose-induced insulin release during the spontaneous remission of streptozotocin diabetes induced in the newborn rats. Diabetes 34:574-579.
93. Portha B, Kergoat M, Blondel O, et al. (1995) Pathogenesis of impaired insulin action in rat models of insulin deficiency. In Lessons from Animal Diabetes, ed. Shafrir E. Smith-Gordon, London, 5:83-91.
94. Portha B, Levacher C, Picon L, Rosselin G. (1974) Diabetogenic effect of streptozotocin during the perinatal period in the rat. Diabetes 23:889-895.
95. Portha B, Picon L. (1982) Insulin treatment improves the spontaneous remission of neonatal streptozotocin diabetes in the rat. Diabetes 31:165-169.
96. Portha B, Picon L, Rosselin G. (1979) Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17:371-377.
97. Portha B, Serradas P, Bailbe D, et al. (1993) Effect of Benfluorex on insulin secretion and insulin action in streptozotocin diabetic rats. Diabetes Metab Rev 9:57-63.
98. Portha B, Serradas P, Blondel O, et al. (1988) Relation between hyperglycemia and impairment of insulin secretion and action. Information from the n-STZ rat models. In Lessons from Animal Diabetes, ed. Shafrir E. Smith-Gordon, London, 3:334-341.
99. Reaven GM. (1980) How high the carbohydrate? Diabetologia 19:409-413.
100. Reaven GM, Sageman WS, Swenson RS. (1977) Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency. Diabetologia 13:459-462.
101. Rerup C. (1980) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22:485-518.
102. Schaffer S, Tan B, Wilson G. (1985) Development of a cardiomyopathy in a model of noninsulin- dependent diabetes. Am J Physiol 248:H179-H185.
103. Schaffer SW, Mozaffari S, Artman M, Wilson G. (1989) Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes. Am J Physiol 256:E25-E30.
104. Schaffer SW, Seyed-Mozaffari M, Cutcliff CR, Wilson GL. (1986) Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes mellitus. Diabetes 35:593-597.
105. Serradas P, Bailbé D, Blondel O, Portha B. (1991) Abnormal B-cell function in rats with noninsulin dependent diabetes induced by neonatal streptozotocin: Effect of in vivo insulin, phlorizin or vanadate treatments. Pancreas 6:54-62.
106. Serradas P, Bailbé D, Portha B. (1989) Chronic gliclazide treatment improves the in vitro glucose-induced insulin release in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin. Diabetologia 32:577-584.
107. Serradas P, Blondel O, Bailbé D, Portha B. (1993) Benfluorex normalizes basal hyperglycemia and reverses hepatic resistance in streptozotocin-diabetic rats. Diabetes 43:564-570.
108. Shinde UA, Mehta AA, Goyal RK. (2001) Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent diabetes. Indian J Exp Biol 39:864-870.
109. Thorens B, Weir GC, Leahy JL, et al. (1990) Reduced expression of the liver/beta cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc Natl Acad Sci USA 87:6492-6496.
110. Thyssen S, Arany E, Hill DJ. (2006) Ontogeny of regeneration of beta-cell in the neonatal rat following treatment with streptozotocin. Endocrinology 147:2346-2356.
111. Tormo MA, Leon-Quinto T, Saulnier C, et al. (1997) Insulin secretion and glucose tolerance after islet transplantation in rats with non-insulin dependent diabetes induced by neonatal streptozotocin. Cell Transplant 6:23-32.
112. Tourrel C, Bailbè D, Meile MJ, et al. (2001) Glucagon-like peptide-1 and exendin-4 stimulate b-cell neogenesis in streptozotocin treated newborn rats, resulting in persistently improved glucose homeostasis at adult age. Diabetes 50:1562-1570.
113. Trent DF, Fletcher DJ, May JM, et al. (1984) Abnormal islet and adipocyte function in young b-cell deficient rats with near normoglycemia. Diabetes 33:170-175.
114. Triadou N, Portha B, Picon L, Rosselin G. (1982) Experimental chemical diabetes and pregnancy in the rat. Evolution of glucose tolerance and insulin response. Diabetes 31:75-79.
115. Tsuura Y, Ishida H, Okamoto Y, et al. (1992) Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic B-cells in streptozotocin-induced NIDDM rats. Diabetes 41:861-865.
116. Umeda F, Inoue K, Hirano K, et al. (1992) Alterations in femoral bone histomorphometry and vitamin D metabolism in neonatal streptozotocin-induced diabetic rat. Fukuoka Igaku Zasshi 83:403-408.
117. Wada M, Iwase M, Wakisaka M, et al. (1995) A new model of diabetic pregnancy with genetic hypertension: Pregnancy in spontaneously hypertensive rats with neonatal streptozotocin- induced diabetes. Am J Obstet Gynecol 72:626-630.
118. Wakisaka M, Nunoi K, Iwase M, et al. (1988) Early development of nephropathy in a new model of spontaneously hypertensive rat with non-insulin-dependent diabetes mellitus. Diabetologia 31:291-296.
119. Wang RN, Bouwens L, Klppel G. (1994) Beta-cell proliferation in normal and streptozotocintreated newborn rats: Site, dynamics and capacity. Diabetologia 37:1088-1096.
120. Weir GC, Clore EE, Zmachinsky CJ, Bonner-Weir S. (1981) Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 30:590-595.
121. Weir GC, Leahy JL, Bonner-Weir S. (1986) Experimental reduction of B-cell mass: Implications for the pathogenesis of diabetes. Diabetes Metab Rev 2:125-161.
122. Welsh N, Hellerström C. (1990) In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology 126:1842-1848.
123. Welsh N, Pääbo S, Welsh M. (1991) Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin. Diabetologia 34:626-631.
124. York DA, Bray GA. (1972) Dependence of hypothalamic obesity on insulin, the pituitary and the adrenal gland. Endocrinology 90:885-894.
125. Young TK, Liu AC. (1965) Hyperphagia, insulin and obesity. Chin J Physiol 19:247-253.